Latest Breaking News On - Long acting beta agonist - Page 1 : comparemela.com

AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024

/PRNewswire/ Amgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International.

United statesSan diegoPuerto ricoKate meyerJessica akopyanJustin claeysLymphopoietin isoformsJay bradnerWorld most innovative companiesEmergency department visit in patientsTeneobio incChemocentryx incInternational conferenceDrug administrationExchange commissionKyowa kirin co ltd

Verona Pharma Ensifentrine: A New Era In Respiratory Disease Treatment (NASDAQ:VRNA)

Verona Pharma Ensifentrine: A New Era In Respiratory Disease Treatment (NASDAQ:VRNA)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofMylan viatrisChiesi farmaceuticiVerona pharmaUltibro breezhalerBoehringer ingelheimTeva pharmaceutical industriesInvestor update commercial presentationBig pharmaLong acting muscarinic antagonistLong acting beta agonistInhaled corticosteroidsNew drug applicationNuance pharma

Weekend Doctor: Asthma

Weekend Doctor: Asthma
blufftonicon.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from blufftonicon.com Daily Mail and Mail on Sunday newspapers.

United statesJami kozielSupplemental nutrition assistance programBlanchard valley health systemPulmonary servicesBlanchard valley healthAfrican americanHispanic whiteLong acting beta agonistInhaled corticosteroids

Respiratory Inhaler Devices Market to grow at 4 4% CAGR through 2030, Says Future Market Insights

Respiratory Inhaler Devices Market to grow at 4.4% CAGR through 2030, Says Future Market Insights

New yorkUnited statesUnited arab emiratesZydus cadilaMarket research expertMarket researchSmart inhaler technologyGreater new york chamberWorld health organizationRespiratory inhaler devicesInhaler technology toutedEast asiaTailored made reportMatch yourMetered dose inhalerLong acting beta agonist

Respiratory Inhalers Market to grow at 4 4% CAGR through 2030, driven by rising prevalence of COPD and Asthma

Respiratory Inhalers Market to grow at 4.4% CAGR through 2030, driven by rising prevalence of COPD and Asthma.

United arab emiratesZydus cadilaMarket research expertSmart inhaler technologySee campaignResearch newswireWorld health organizationRespiratory inhaler devicesInhaler technology toutedMajor breakthroughsmartEast asiaMetered dose inhalerLong acting beta agonistLong acting muscarinic antagonistRequest customizationFuture market insights